Varex Imaging $VREX Shares Sold by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. lessened its stake in shares of Varex Imaging (NASDAQ:VREX) by 13.3% in the first quarter, Holdings Channel.com reports. The fund owned 461,887 shares of the company’s stock after selling 70,861 shares during the quarter. Assenagon Asset Management S.A.’s holdings in Varex Imaging were worth $4,901,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of VREX. Empowered Funds LLC raised its position in shares of Varex Imaging by 7.3% during the first quarter. Empowered Funds LLC now owns 179,128 shares of the company’s stock worth $2,078,000 after purchasing an additional 12,151 shares during the period. Jane Street Group LLC boosted its position in shares of Varex Imaging by 17.9% in the 1st quarter. Jane Street Group LLC now owns 159,362 shares of the company’s stock valued at $1,849,000 after purchasing an additional 24,160 shares during the period. Rhumbline Advisers boosted its position in shares of Varex Imaging by 4.6% in the 2nd quarter. Rhumbline Advisers now owns 61,820 shares of the company’s stock valued at $536,000 after purchasing an additional 2,694 shares during the period. Hsbc Holdings PLC increased its stake in Varex Imaging by 19.7% in the 2nd quarter. Hsbc Holdings PLC now owns 47,525 shares of the company’s stock worth $408,000 after purchasing an additional 7,825 shares in the last quarter. Finally, Quantbot Technologies LP increased its stake in Varex Imaging by 25.1% in the 2nd quarter. Quantbot Technologies LP now owns 47,292 shares of the company’s stock worth $410,000 after purchasing an additional 9,476 shares in the last quarter.

Analyst Ratings Changes

A number of research firms have commented on VREX. Wall Street Zen lowered shares of Varex Imaging from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Weiss Ratings reissued a “sell (d-)” rating on shares of Varex Imaging in a research report on Wednesday, June 24th. Finally, Zacks Research upgraded shares of Varex Imaging from a “hold” rating to a “strong-buy” rating in a report on Monday, April 13th. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Varex Imaging presently has a consensus rating of “Moderate Buy” and a consensus target price of $16.17.

Varex Imaging Stock Performance

Shares of NASDAQ VREX opened at $9.98 on Tuesday. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.20 and a quick ratio of 1.43. Varex Imaging has a one year low of $6.76 and a one year high of $14.56. The business’s 50-day moving average price is $10.68 and its two-hundred day moving average price is $11.80. The company has a market capitalization of $420.16 million, a P/E ratio of -4.99 and a beta of 0.91.

Varex Imaging (NASDAQ:VREX) last posted its quarterly earnings results on Thursday, May 7th. The company reported $0.21 earnings per share for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.01). The firm had revenue of $216.00 million for the quarter, compared to analysts’ expectations of $216.92 million. Varex Imaging had a positive return on equity of 8.19% and a negative net margin of 9.64%.Varex Imaging has set its Q3 2026 guidance at 0.150-0.300 EPS. Analysts anticipate that Varex Imaging will post 0.93 earnings per share for the current fiscal year.

Varex Imaging Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.